RIPK2 and malignant colon neoplasm: Exploring the Human Protein Atlas, immunohistochemistry analysis was carried out for patients with colon cancer and those with rectal cancer, even though no results were significant, but the patients with rectal cancer were the only ones who showed results similar to our analysis, in which patients with higher expression of RIPK2 showed more death (data not shown).